← Leaderboards
Federico Innocenti
University Of Chicago
$1,985,541
Attributed
$1,985,541
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $663.4K · FY2009–15$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,985,541 · 4
By mechanism
R21$1,337,295 · 3
K07$648,246 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Marsha R Rosner$15,100,833
- Marcus E Peter$21,803,126
- Mark J Ratain$26,736,475
- Michael L. Maitland$2,225,073
- Jonathan K Pritchard$21,116,118
Others in their field
Top investigators on “Single Nucleotide Polymorphism”
- David Heimbrook · Leidos Biomedical Research, Inc.$45,173,190
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$38,021,340
- Li-San Wang · University Of Pennsylvania$32,532,677
- Aravinda Chakravarti · Johns Hopkins University$31,019,191
- Stacey Gabriel · Broad Institute, Inc.$30,965,067
- Gerard David Schellenberg · University Of California San Diego$29,570,176
Research focus
Single Nucleotide PolymorphismGenesGeneticVariation (Genetics)AngiogenesisBaseVariantGenotypePatternPharmaceutical PreparationsPredispositionCancer PatientGenome-WidePhase Iii Clinical TrialsRandomizedMolecular GeneticsMalignant NeoplasmsPathway InteractionsBiologicalIn VitroClinical TrialsMolecularCandidate Disease GeneGenome Wide Association Study
Grant awards (14)
A new model for discovering genetic determinants of angiogenesis and the effect o$198,360
R21 · FY2015 · CA · contact PI
A new model for discovering genetic determinants of angiogenesis and the effect o$165,300
R21 · FY2014 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$130,043
K07 · FY2013 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$130,502
K07 · FY2012 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$131,139
K07 · FY2011 · CA · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$193,050
R21 · FY2010 · DK · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$169,065
R21 · FY2010 · DK · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$161,021
R21 · FY2010 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$108,004
K07 · FY2010 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$21,694
K07 · FY2010 · CA · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$10,579
R21 · FY2010 · CA · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$234,000
R21 · FY2009 · DK · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$205,920
R21 · FY2009 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$126,864
K07 · FY2009 · CA · contact PI